STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrugresistant tuberculosis (MDR-TB), and the first phase III trial to test the efficacy and safety of Bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
The trial established a Community Engagement (CE) Plan. The CE program was implemented at thirteen research sites within the STREAM trial, in seven countries. This paper sets out a summary of the experiences of CABs in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research. In conclusion, the experiences gained during STREAM, lead to both growing confidence in CE as a valuable process and community participation in advocacy.
Recent Abstracts
Trouble Brewing – The Case for Alcohol Policy (Second Edition)
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Clean Air in Jakarta: Gaps and Possibilities Toward Low Emission Practices
Public Attitudes Towards Alcohol Policy: South Africa
Quality Assurance and Improvement Framework for Medical Certification of Cause of Death and…
More Data Better Health: Climate and Health in the Legal Amazon
Mais Dados Mais Saúde: Clima e Saúde na Amazônia Legal
Health Taxes Action Guide
Opinión pública frente a la política de alcohol: Colombia